Literature DB >> 20383176

Receptor-interacting protein (RIP) kinase family.

Duanwu Zhang1, Juan Lin, Jiahuai Han.   

Abstract

Receptor-interacting protein (RIP) kinases are a group of threonine/serine protein kinases with a relatively conserved kinase domain but distinct non-kinase regions. A number of different domain structures, such as death and caspase activation and recruitment domain (CARD) domains, were found in different RIP family members, and these domains should be keys in determining the specific function of each RIP kinase. It is known that RIP kinases participate in different biological processes, including those in innate immunity, but their downstream substrates are largely unknown. This review will give an overview of the structures and functions of RIP family members, and an update of recent progress in RIP kinase research.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20383176      PMCID: PMC4003224          DOI: 10.1038/cmi.2010.10

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  85 in total

Review 1.  The RIP kinases: crucial integrators of cellular stress.

Authors:  Etienne Meylan; Jürg Tschopp
Journal:  Trends Biochem Sci       Date:  2005-03       Impact factor: 13.807

2.  TRIP6 is a RIP2-associated common signaling component of multiple NF-kappaB activation pathways.

Authors:  Lianyun Li; Liang-Hua Bin; Fu Li; Yi Liu; Danying Chen; Zhonghe Zhai; Hong-Bing Shu
Journal:  J Cell Sci       Date:  2005-01-18       Impact factor: 5.285

3.  RIP3, a novel apoptosis-inducing kinase.

Authors:  X Sun; J Lee; T Navas; D T Baldwin; T A Stewart; V M Dixit
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

4.  Mouse receptor interacting protein 3 does not contain a caspase-recruiting or a death domain but induces apoptosis and activates NF-kappaB.

Authors:  N J Pazdernik; D B Donner; M G Goebl; M A Harrington
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

5.  FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.

Authors:  C P Lawrence; S C Chow
Journal:  FEBS Lett       Date:  2005-11-02       Impact factor: 4.124

6.  LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain.

Authors:  Daniel Korr; Luisella Toschi; Peter Donner; Hans-Dieter Pohlenz; Bertolt Kreft; Bertram Weiss
Journal:  Cell Signal       Date:  2005-10-21       Impact factor: 4.315

7.  IKK1-deficient mice exhibit abnormal development of skin and skeleton.

Authors:  Q Li; Q Lu; J Y Hwang; D Büscher; K F Lee; J C Izpisua-Belmonte; I M Verma
Journal:  Genes Dev       Date:  1999-05-15       Impact factor: 11.361

8.  Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.

Authors:  Alexander Zimprich; Saskia Biskup; Petra Leitner; Peter Lichtner; Matthew Farrer; Sarah Lincoln; Jennifer Kachergus; Mary Hulihan; Ryan J Uitti; Donald B Calne; A Jon Stoessl; Ronald F Pfeiffer; Nadja Patenge; Iria Carballo Carbajal; Peter Vieregge; Friedrich Asmus; Bertram Müller-Myhsok; Dennis W Dickson; Thomas Meitinger; Tim M Strom; Zbigniew K Wszolek; Thomas Gasser
Journal:  Neuron       Date:  2004-11-18       Impact factor: 17.173

9.  Kinase activity is required for the toxic effects of mutant LRRK2/dardarin.

Authors:  Elisa Greggio; Shushant Jain; Ann Kingsbury; Rina Bandopadhyay; Patrick Lewis; Alice Kaganovich; Marcel P van der Brug; Alexandra Beilina; Jeff Blackinton; Kelly Jean Thomas; Rili Ahmad; David W Miller; Sashi Kesavapany; Andrew Singleton; Andrew Lees; Robert J Harvey; Kirsten Harvey; Mark R Cookson
Journal:  Neurobiol Dis       Date:  2006-06-05       Impact factor: 5.996

10.  Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.

Authors:  Coro Paisán-Ruíz; Shushant Jain; E Whitney Evans; William P Gilks; Javier Simón; Marcel van der Brug; Adolfo López de Munain; Silvia Aparicio; Angel Martínez Gil; Naheed Khan; Janel Johnson; Javier Ruiz Martinez; David Nicholl; Itxaso Martí Carrera; Amets Saénz Pena; Rohan de Silva; Andrew Lees; José Félix Martí-Massó; Jordi Pérez-Tur; Nick W Wood; Andrew B Singleton
Journal:  Neuron       Date:  2004-11-18       Impact factor: 17.173

View more
  66 in total

Review 1.  Programmed necrosis: backup to and competitor with apoptosis in the immune system.

Authors:  Jiahuai Han; Chuan-Qi Zhong; Duan-Wu Zhang
Journal:  Nat Immunol       Date:  2011-11-16       Impact factor: 25.606

Review 2.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

Review 3.  Targeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic Steatohepatitis.

Authors:  Alexander Wree; Wajahat Z Mehal; Ariel E Feldstein
Journal:  Semin Liver Dis       Date:  2016-02-12       Impact factor: 6.115

4.  RIPK1 binds to vitamin D receptor and decreases vitamin D-induced growth suppression.

Authors:  Waise Quarni; Panida Lungchukiet; Anfernee Tse; Pei Wang; Yuefeng Sun; Ravi Kasiappan; Jheng-Yu Wu; Xiaohong Zhang; Wenlong Bai
Journal:  J Steroid Biochem Mol Biol       Date:  2017-02-01       Impact factor: 4.292

5.  PKK deletion in basal keratinocytes promotes tumorigenesis after chemical carcinogenesis.

Authors:  Luojing Chen; Matthew S Hayden; Elaine S Gilmore; Carolina Alexander-Savino; David Oleksyn; Kathleen Gillespie; Jiyong Zhao; Brian Poligone
Journal:  Carcinogenesis       Date:  2018-03-08       Impact factor: 4.944

Review 6.  Regulation of tumour necrosis factor signalling: live or let die.

Authors:  Dirk Brenner; Heiko Blaser; Tak W Mak
Journal:  Nat Rev Immunol       Date:  2015-06       Impact factor: 53.106

7.  The Receptor-interacting Serine/Threonine Protein Kinase 1 (RIPK1) Regulates Progranulin Levels.

Authors:  Amanda R Mason; Lisa P Elia; Steven Finkbeiner
Journal:  J Biol Chem       Date:  2017-01-09       Impact factor: 5.157

Review 8.  RIP kinases: key decision makers in cell death and innate immunity.

Authors:  F Humphries; S Yang; B Wang; P N Moynagh
Journal:  Cell Death Differ       Date:  2014-08-22       Impact factor: 15.828

9.  Dual Inhibition of Rip2 and IRAK1/4 Regulates IL-1β and IL-6 in Sarcoidosis Alveolar Macrophages and Peripheral Blood Mononuclear Cells.

Authors:  Jaya Talreja; Harvinder Talwar; Nisar Ahmad; Ruchi Rastogi; Lobelia Samavati
Journal:  J Immunol       Date:  2016-07-11       Impact factor: 5.422

10.  RIP1 upregulation promoted tumor progression by activating AKT/Bcl-2/BAX signaling and predicted poor postsurgical prognosis in HCC.

Authors:  Cong Wang; Bowen Yao; Meng Xu; Xin Zheng
Journal:  Tumour Biol       Date:  2016-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.